Olympus Corporation (7733.T)
Makes medical cameras and surgical tools for doctors to see inside patients' bodies.
1,862.50+0.03%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+2.1%
The outlook
Olympus is trading above both its 50- and 200-day moving averages, sitting roughly two-thirds of the way up its 52-week range. Analyst consensus leans toward "Hold," with an average price target about 3% above the current level. The stock carries a trailing P/E of 30.4 and a StockGlow lean toward bullish, though analyst coverage shows mixed sentiment.
What’s behind the score
Analyst consensusHold — 2.6 avg of 13 analysts
Price trendAbove its 50- & 200-day averages
52-week range65% of the way from its 52-week low to high
Price targetAvg target +3% vs current price
Analyst price target
~12-month · 13 analysts1,913.08average target+2.7% vs now
Now 1,862.50
Low 1,600.00High 2,300.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.98T
52-wk high
2,168.00
52-wk low
1,302.50
50-day avg
1,757.16
200-day avg
1,773.22
Trailing P/E
30.4